Caring Cross

Imagine a world without disease. Let's join forces to accelerate the development of advanced medicines and ensure access to cures for all patients, everywhere.

[Caring Cross @caring_cross]

Excited to see today’s feature in WIRED highlighting the growing potential of CAR-T cell therapy for long-term #HIV control and the promising early clinical data presented at #ASGCT2026.
https://t.co/qEROq3hzf0
#CellTherapy #GeneTherapy #GlobalHealth #HealthEquity #Biotechnology

[Caring Cross @caring_cross]

Nigeria is stepping into the future of medicine
“It was my honor to be hosted by Hon. Minister Dr. Iziaq Adekunle Salako. Let us work together to bring affordable and accessible cellular and gene therapies to Nigeria.” —Boro Dropulić
https://t.co/WaPwtommOO
#HealthEquity #Nigeria

[Federal Ministry of Health, NIGERIA @Fmohnigeria]

FEDERAL MINISTRY OF HEALTH AND SOCIAL WELFARE
Press Release

NIGERIA TARGETS BREAKTHROUGH THERAPIES IN NEW PUSH FOR MEDICINE SECURITY

Abuja, Nigeria| 05 May 2026 —The Federal Government has launched a new push to expand access to advanced medical treatments in Nigeria, positioning gene therapy and other frontier technologies as central to the country’s long-term medicine security strategy.

This direction was outlined during a high-level engagement in Abuja between the Federal Ministry of Health and Social Welfare, global non-profit Caring Cross, and key research and industry partners.

The Honourable Minister of State for Health and Social Welfare, Dr. Iziaq Adekunle Salako, said Nigeria is moving deliberately to close the gap between scientific discovery and patient access, particularly in areas where life-saving treatments remain out of reach for many.

He emphasised that the President Tinubu led administration is prioritising health innovation as part of its broader efforts to strengthen national resilience, drive local production, and reduce dependence on external supply chains.

At the centre of the discussions was the potential introduction of Chimeric Antigen Receptor (CAR) T-cell therapy, an advanced form of treatment showing promise in managing conditions such as sickle cell disease and certain blood cancers.

While widely explored in other regions, CAR-T therapy remains largely inaccessible across Africa. The Minister noted that changing this reality requires deliberate investment in research, partnerships, and the systems needed to translate innovation into real-world care.
“Our goal is clear, to ensure that breakthroughs in science are not distant concepts, but accessible solutions for Nigerians,” he said.

The engagement also highlighted Nigeria’s ongoing pharmaceutical and research reforms, anchored by the Presidential Initiative on Vaccine and Biologicals Production (PVAC), aimed at strengthening local manufacturing, expanding vaccine and biological production, and building a more coordinated innovation ecosystem.

In her remarks, the Permanent Secretary, Daju Kachollom S. mni, represented by the Director, Health Planning, Research & Statistics, described the meeting as a convergence of science, policy, and opportunity.

Daju noted that emerging fields such as gene therapy and regenerative medicine are redefining modern healthcare and present an important opportunity for Nigeria to leapfrog traditional limitations in access to treatment. “Partnerships like this are critical to ensuring that innovation translates into sustainable improvements in our health system,” she said.

Caring Cross Chief Executive Officer, Dr. Boro Dropulic, highlighted the organisation’s work in expanding access to cellular and gene therapies globally, with a focus on affordability and scalability in low- and middle-income countries. He pointed to the rising burden of genetic and blood-related diseases in Nigeria, particularly among children, as a compelling case for accelerating access to next-generation treatments.

Also contributing, the Director-General of the National Institute of Pharmaceutical Research and Development, Dr. Obi Adigwe, outlined steps already taken to position Nigeria as a leader in pharmaceutical research and development on the continent. These include securing major international research funding, strengthening regional collaboration, and advancing infrastructure for local production of active pharmaceutical ingredients.

He noted that Nigeria is increasingly adopting a coordinated, multi-sector approach that brings together government institutions, research bodies, and global partners to drive innovation at scale.

The meeting marks an early but significant step in Nigeria’s ambition to move from being a consumer of advanced therapies to an active participant in their development, adaptation, and delivery.

Ado Bako
Assistant Director, Information & Public Relations

[Caring Cross @caring_cross]

BioCurie will receive up to $9.3M from ARPA-H to build an AI-powered platform for scalable, data-driven gene therapy manufacturing. We’re honored to collaborate, to accelerate innovation and expand access.
Learn more: https://t.co/m7O05HD2PF
#AdvancedTherapies #BioCurie #ARPAH

[Caring Cross @caring_cross]

We’re excited to announce a new collaboration in Croatia supporting CAR-T cell manufacturing at the Sisters of Mercy University Hospital GMP facility, in partnership with the Zora Foundation.

#GlobalHealth #CARTcellTherapy #HealthEquity #Croatia

[Caring Cross @caring_cross]

In case you missed it, here's a great talk with Caring Cross, Executive Director, Dr. Boro Dropulic on cell therapy cost-reduction and other sustainable approaches.
https://t.co/KVce0X8seY

[Caring Cross @caring_cross]

Caring Cross announces a new partnership with Amrita Research Center Delhi & Amrita Vishwa Vidyapeetham to bring affordable cell & gene therapies to underserved communities across India — a major step toward true health equity.
https://t.co/IpVGQn39P8
#CellTherapy #HealthEquity

[Caring Cross @caring_cross]

How is the pharmaceutical industry addressing global health inequities?
Read the full article here:
🔗 https://t.co/8h6SySVsfv

#HealthEquity #GlobalHealth #CaringCross #PharmaForAll #AdvancedTherapies #TechnologyTransfer

[Caring Cross @caring_cross]

Join us June 20 for our next Biotech Seminar with Dr. Marcos de Lima (Ohio State). Learn from 15+ years of CAR-T experience in U.S. academic centers & the future of decentralized manufacturing.

🕒 3PM ET | 🔗 Register: https://t.co/aqCj39wR2A
#CARTtherapy #CellTherapy

[Caring Cross @caring_cross]

🔬 Biotech Seminar – Today!
T Cell Selection: A Critical Step in the CAR-T Process
Presenter: Dr. Kevin Curran, PhD

🔗 Register: https://t.co/zXCiz2wIJi

#CARTtherapy #BiotechWebinar #CellTherapy #TCellSelection #HealthEquity #PatientAccess #CAR_T #Immunotherapy

[Caring Cross @caring_cross]

Biotech Webinar – June 6 @ 3PM ET
T Cell Selection: A Critical Step in the CAR-T Process
How do we isolate T cells—and why does it matter for access?

🔗 Register: https://t.co/aqCj39wR2A

#CART #CellTherapy #Biotech #HealthEquity

[Caring Cross @caring_cross]

Our Biotech Educational Seminar is about to start in the next hour.
✨ Topic: Genetic Therapy in Sickle Cell Disease: Targeting BCL11A with Lentivirus shmiR
🗓 May 16 | 🕒 3:00 PM ET / 12:00 PM PT / 9:00 PM CET
Join now: https://t.co/geOmowYZRs
#SickleCellAwareness

[Caring Cross @caring_cross]

🔬 Don’t miss this biotech webinar!
Dr. David Williams presents:
Genetic Therapy in Sickle Cell Disease: Targeting BCL11A with #Lentivirus shmiR

🗓️ May 16 | 🕒 3PM EST
👉 Register: https://t.co/aqCj39wR2A

#GeneTherapy #SickleCell #CAR_T #CellTherapy #HarvardUniversity

[Caring Cross @caring_cross]

Thank you to everyone who joined today’s “Unlocking Next-Gen Therapies” event! Grateful to @CancerResrch & @ParkerICI for organizing, and to the incredible panelists for an insightful discussion.
Missed it? https://t.co/eg6GIpuHqZ
#CellTherapy #HealthEquity #AccessForAll

[Caring Cross @caring_cross]

Join us TODAY for our 🔬 Biotech Educational Series
In vivo CAR-T therapy is transforming the field of cell and gene therapy — offering a bold alternative to traditional ex vivo CAR-T.
👉 https://t.co/kffZNHH0xU
#GeneTherapy #InVivoTherapy #CellTherapy #Lentivirus

[Caring Cross @caring_cross]

Health equity means everyone has access to life-saving innovation.
That’s why Caring Cross and @WellbeingAfrica are joining forces to bring #AdvancedTherapies to Nigeria—led by science, grounded in justice. 🌍

🔗 https://t.co/wtQO9V42hD
#GlobalHealth #HealthEquity #WBFA

[Caring Cross @caring_cross]

Join us May 2 at 3PM ET for a biotech webinar on The Future of In Vivo CAR-T — a game-changing approach to engineer T cells inside the body. Learn about the science, clinical updates & delivery tools like lentivirus. Register 👉 https://t.co/aqCj39wR2A
#CART #GeneTherapy

[Caring Cross @caring_cross]

Proud to share our Exec. Director, Boro Dropulic, will speak at #WHSNewDelhi2025 on Nature Portfolio’s panel:

🧬 How to Broaden Access to Gene Therapy in the Global South
📍 New Delhi | 🗓️ Apr 26, 13:30
🔗 https://t.co/r9y2c959UL

#WHA2025 #GlobalSouthInnovation #India

[Caring Cross @caring_cross]

Join us for our Biotech Educational Seminar:
The Importance of Public Benefit Corporations in Rare Disease Gene Therapy
With Dr. Paul Ayoub, CEO of Rarity PBC

🔗 Register: https://t.co/NAQtEnmf2l
#Biotech #CGT #GeneTherapy #lentiviralvector #CaringCross #lentiviral #hemophilia

[Caring Cross @caring_cross]

“Caring Cross is committed to working with governments and healthcare institutions around the world to make this vision a reality.”
— Boro Dropulić, Executive Director, Caring Cross
🔗 https://t.co/Ig0kQUFrYT
#HealthEquity #CellTherapy #CART #UAE #Biotech #GlobalHealth

[Caring Cross @caring_cross]

🔬 Biotech Educational Series: Upcoming Seminar
✨ Topic: The Importance of Public Benefit Corporations in Rare Disease Gene Therapy
With Dr. Paul Ayoub

📅 Date: April 18
⏰ Time: 3:00 PM EST
🔗 Register now: https://t.co/NAQtEnmf2l
#GeneTherapy #BiotechForGood #PublicBenefit